Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.05B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$404M |
| 3 |
AstraZeneca
AZN
|
+$342M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$288M |
| 5 |
Willis Towers Watson
WTW
|
+$227M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icahn Enterprises
IEP
|
+$641M |
| 2 |
Microsoft
MSFT
|
+$549M |
| 3 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$538M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$294M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.22% |
| 2 | Financials | 7.52% |
| 3 | Healthcare | 6.46% |
| 4 | Consumer Discretionary | 6.41% |
| 5 | Communication Services | 4.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Blackbaud
BLKB
$1.95B
| $5.65M | ﹤0.01% |
73,796
-267
| -0.4% | -$19.2K |
|
1777
Clean Energy Fuels
CLNE
$421M
| $5.64M | ﹤0.01% |
555,923
+278,852
| +101% | +$2.88M |
|
|
VNET
1778
VNET Group
VNET
$1.77B
| $5.63M | ﹤0.01% |
245,330
-23,316
| -9% | -$594K |
|
1779
Axalta
AXTA
$7.56B
| $5.63M | ﹤0.01% |
184,560
-17,072
| -8% | -$540K |
|
1780
Ocugen
OCGN
$403M
| $5.61M | ﹤0.01% |
698,866
+294,657
| +73% | +$2.49M |
|
1781
CALL
Union Pacific
UNP
$173B
| $5.61M | ﹤0.01% |
25,500
+8,900
| +54% | +$1.98M |
|
1782
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.15B
| $5.59M | ﹤0.01% |
160,046
+10,850
| +7% | +$372K |
|
1783
LGI Homes
LGIH
$1.38B
| $5.59M | ﹤0.01% |
34,531
+4,490
| +15% | +$743K |
|
1784
CALL
iShares MSCI South Korea ETF
EWY
$20.3B
| $5.59M | ﹤0.01% |
60,000
-285,000
| -83% | -$26.2M |
|
|
1785
PUT
iShares MSCI South Korea ETF
EWY
$20.3B
| $5.59M | ﹤0.01% |
60,000
-15,000
| -20% | -$1.38M |
|
|
EPAY
1786
DELISTED
Bottomline Technologies Inc
EPAY
| $5.58M | ﹤0.01% |
150,575
+51,664
| +52% | +$2.13M |
|
1787
Affiliated Managers Group
AMG
$9.63B
| $5.58M | ﹤0.01% |
36,199
-15,084
| -29% | -$2.41M |
|
1788
PUT
FirstEnergy
FE
$29B
| $5.58M | ﹤0.01% |
150,000
-900,000
| -86% | -$33.5M |
|
1789
Banco Santander
SAN
$194B
| $5.58M | ﹤0.01% |
1,426,951
+69,577
| +5% | +$270K |
|
1790
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
| $5.58M | ﹤0.01% |
68,893
-18,726
| -21% | -$1.46M |
|
1791
CareTrust REIT
CTRE
$10.1B
| $5.58M | ﹤0.01% |
240,083
+96,501
| +67% | +$2.27M |
|
1792
Varex Imaging
VREX
$466M
| $5.58M | ﹤0.01% |
207,951
-40,616
| -16% | -$996K |
|
|
MRTX
1793
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.58M | ﹤0.01% |
34,511
+5,056
| +17% | +$812K |
|
1794
COPT Defense Properties
CDP
$4.37B
| $5.57M | ﹤0.01% |
198,817
+29,155
| +17% | +$815K |
|
1795
Iovance Biotherapeutics
IOVA
$2.02B
| $5.56M | ﹤0.01% |
213,825
+48,618
| +29% | +$1.26M |
|
1796
Halozyme
HALO
$9.88B
| $5.54M | ﹤0.01% |
121,964
-91,747
| -43% | -$4.06M |
|
1797
Regenxbio
RGNX
$615M
| $5.54M | ﹤0.01% |
142,517
-2,941
| -2% | -$105K |
|
|
BLUE
1798
DELISTED
bluebird bio
BLUE
| $5.53M | ﹤0.01% |
13,357
+266
| +2% | +$105K |
|
1799
PUT
Tyson Foods
TSN
$21.5B
| $5.53M | ﹤0.01% |
75,000
+54,900
| +273% | +$4.26M |
|
1800
Veracyte
VCYT
$4.43B
| $5.52M | ﹤0.01% |
138,009
+51,650
| +60% | +$2.21M |
|
Similar funds
Citigroup's Q2 2021 Portfolio in Review
As of Q2 2021, Citigroup held 6,654 positions worth $166B, up 7.5% from $155B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup's Q2 2021 filing shows 397 new, 2,681 increased, 2,205 reduced and 444 closed positions. Its largest new stake was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M. The largest sale was Icahn Enterprises, an estimated $641M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q2 2021 buy was Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant: 7,128,000 shares worth $71.4M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $2.05B increase.
- Citigroup's biggest Q2 2021 reduction was Icahn Enterprises, cutting an estimated $641M.
- Citigroup fully exited RealPage, Inc. in Q2 2021, selling an estimated $226M.
- Citigroup's ten largest holdings make up 20% of its $166B portfolio in Q2 2021.
- Citigroup opened 397 new positions and closed 444 in Q2 2021.
- Citigroup's portfolio value rose 7.5% quarter-over-quarter to $166B.
Based on Citigroup's 13F filing for Q2 2021, filed 10 Aug 2021.